BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, April 19, 2026
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Regulatory actions for May 1, 2023

May 1, 2023
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Casana, Concept Medical, Medtronic, Nano-X Imaging, Tempus.
Read More

Other news to note for May 1, 2023

May 1, 2023
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Biosynex, Chembio, Elevage, Global Medical, Inspiremd, Ossis, Patient Square, Rapid Surgical, Rockwell Medical, Surgical Safety, Zimmer Biomet.
Read More

In the clinic for May 1, 2023

May 1, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Preludedx.
Read More

Financings for May 1, 2023

May 1, 2023
Med-tech firms raising money in public or private financings, including: Medshift, Pulse.
Read More

Appointments and advancements for May 1, 2023

May 1, 2023
New hires and promotions in the med-tech industry, including: Bioaffinity Technologies, Cleerly, Immunovia, Neuronetics.
Read More

Regulatory actions for May 1, 2023

May 1, 2023
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bristol Myers Squibb, H. Lundbeck, Moderna, Otsuka, Pfizer, Rnaimmune, Senhwa.
Read More

Other news to note for May 1, 2023

May 1, 2023
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 2seventy, BMS, Gaviton, Immatics, Leidos, Novo Nordisk, Ovid, Sangamo, Silk Road, Soligenix, TFF, Vyne.
Read More

In the clinic for May 1, 2023

May 1, 2023
Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D Molecular, Actinium, Avidity, Inmagene, Kiora, Nanoscope, Olix, Ovid, Takeda, Tempest.
Read More

Financings for May 1, 2023

May 1, 2023
Biopharmas raising money in public or private financings, including: Acelyrin, Fibrogen, Jasper.
Read More

Appointments and advancements for May 1, 2023

May 1, 2023
New hires and promotions in the biopharma industry, including: Alladapt, Avrobio, Biora, Cognition, Esperovax, Galera, Immunovia, In8bio, Inspirna, Repare, Ring.
Read More
Previous 1 2 … 787 788 789 790 791 792 793 794 795 … 1782 1783 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • Novel caspase-2 inhibitor shows in vivo neuroprotective effects

    BioWorld Science
    Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing